Evonik Industries AG (FRA:EVK) has earned an average recommendation of “Hold” from the twenty-two research firms that are covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and ten have given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is €29.12 ($33.86).
EVK has been the subject of a number of research analyst reports. Barclays set a €24.50 ($28.49) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, September 26th. JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, August 1st. UBS Group set a €21.00 ($24.42) price objective on shares of Evonik Industries and gave the stock a “sell” rating in a research report on Monday, September 30th. DZ Bank reaffirmed a “buy” rating on shares of Evonik Industries in a research report on Tuesday, October 1st. Finally, Deutsche Bank set a €38.00 ($44.19) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research report on Thursday, October 3rd.
EVK stock traded up €0.13 ($0.15) during midday trading on Wednesday, reaching €21.62 ($25.14). 462,808 shares of the company were exchanged. The business has a 50-day moving average price of €22.76 and a two-hundred day moving average price of €24.56. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34).
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Further Reading: Diversification
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.